Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze SNDX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SNDX investment potential.

What is SNDX stock price today?

Get real-time SNDX stock price, historical data, and price charts on Financhill. Track SNDX performance with our advanced analysis tools.

Is SNDX a good investment?

Evaluate SNDX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SNDX stock?

To buy SNDX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SNDX?

View detailed market capitalization data and company valuation metrics for SNDX on our comprehensive analysis page.

What is the P/E ratio of SNDX?

Use our fundamental analysis tools to view SNDX P/E ratio and compare valuation metrics with industry peers.

What are SNDX earnings?

View SNDX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Syndax Pharmaceuticals, Inc. 10K Form

Buy

SNDX
Syndax Pharmaceuticals, Inc.

Last Price:

$19.76

Seasonality Move:

16.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02	10Q	SNDX/Syndax Pharmaceuticals, Inc. Quarterly
2023-08-03	10Q	SNDX/Syndax Pharmaceuticals, Inc. Quarterly
2023-05-08	10Q	SNDX/Syndax Pharmaceuticals, Inc. Quarterly
2022-11-03	10Q	SNDX/Syndax Pharmaceuticals, Inc. Quarterly
2022-08-08	10Q	SNDX/Syndax Pharmaceuticals, Inc. Quarterly
2022-05-09	10Q	SNDX/Syndax Pharmaceuticals, Inc. Quarterly

Receive SNDX News And Ratings

See the #1 stock for the next 7 days that we like better than SNDX

SNDX Financial Statistics

Sales & Book Value

Annual Sales:	$23.7M
Cash Flow:	$-70.7M
Price / Cash Flow:	0
Annual Sales:	$1.33
Price / Book:	14.84

Profitability

EPS (TTM):	-3.61530
Net Income (TTM):	$-311.6M
Gross Margin:	$22.8M
Return on Equity:	-136.36%
Return on Assets:	-53%

Syndax Pharmaceuticals, Inc. Earnings Forecast

Key Syndax Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 14 years for SNDX is 96.48%.
The Selling, General & Administrative Expenses for SNDX have been equal to 510.47% of Gross Profit Margin.
The Research & Development expenses have been 1,020.43% of Revenue.
The Net Earning history of SNDX is -1,346.11% of Total Revenues.
Per Share Earnings over the last 14 years have been positive in 6 years.

Syndax Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	SNDX
CUSIP:	87164F
Website:	syndax.com

Debt

Debt-to-Equity Ratio:	2.99
Current Ratio:	4.64
Quick Ratio:	4.18

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

SNDX Technical Analysis vs Fundamental Analysis

Buy

Syndax Pharmaceuticals, Inc. (SNDX) is a Buy

Is Syndax Pharmaceuticals, Inc. a Buy or a Sell?

Syndax Pharmaceuticals, Inc. stock is rated a Buy

The current Syndax Pharmaceuticals, Inc. [SNDX] share price is $19.74. The Score for SNDX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.